XL8 and K-BioX Partner to Support Korean Life Science Researchers with AI Translation.

PRESS RELEASE
February 27, 2025

XL8, a leader in AI-powered real-time interpretation and subtitle solutions, has announced a strategic partnership with K-BioX to support Korean life science researchers in global collaboration and knowledge sharing. K-BioX is a nonprofit organization dedicated to connecting and supporting Korean professionals in the life sciences field worldwide, fostering research exchange and international cooperation.

Through this partnership, XL8’s AI-powered simultaneous interpretation solution, EventCAT, will assist Korean life science researchers in overcoming language barriers, enabling them to seamlessly share research findings and expand international collaborations.

Breaking Language Barriers for Life Science Innovation

XL8’s CEO, Tim Jung, emphasized the importance of this collaboration, stating, "EventCAT will empower researchers to share knowledge and collaborate without linguistic limitations. We are committed to supporting Korean life scientists in effectively engaging with global researchers and achieving greater breakthroughs through our partnership with K-BioX."

Dr. Siyeon Lee, Chair of K-BioX, highlighted the benefits of the collaboration, stating, "By leveraging XL8’s EventCAT, Korean life scientists will be able to communicate their research findings more effectively on a global scale. This partnership is expected to make a tangible impact on research activities and the development of future talent in the life sciences."

EventCAT: AI-Powered Translation for Research & Global Conferences

XL8’s AI-powered interpretation and subtitle solution, EventCAT, supports real-time translation in 42 languages, making it an essential tool for online meetings, academic forums, international conferences, and broadcasting. EventCAT offers three key services:

  • EventCAT OnlineMeeting: Real-time translated subtitles for virtual meeting platforms.
  • EventCAT Conference: Instant translation for large-scale international events and lectures.
  • LiveSubs: AI-generated subtitles for live broadcasts and streaming content, enhancing accessibility for global audiences.

Currently deployed in international conferences, corporate meetings, and academic forums, EventCAT continues to facilitate seamless multilingual communication, fostering global knowledge sharing.

Through this collaboration, XL8 and K-BioX aim to empower Korean life science researchers by providing an advanced AI-driven language solution, ensuring they can share their research freely and expand their global presence. The solution will be applicable not only for virtual meetings and lectures but also for in-person conferences, seminars, and symposiums, further enhancing global research collaboration.

About XL8

Founded in 2019 by former AI experts from Google and Apple, XL8 is a Silicon Valley-based tech startup with an R&D center in South Korea. XL8 has advanced AI machine translation engines trained on vast amounts of media content, enabling highly accurate and domain-specific translations. With its proprietary AI technology, XL8 has translated over 800,000 hours of content, reaching millions of viewers on major OTT platforms. Expanding beyond media localization, XL8 now enhances global communication in online meetings and conferences across 45+ languages. For more information, visit xl8.ai.

About K-BioX

K-BioX is a nonprofit organization dedicated to building a global network for Korean life science professionals and facilitating research exchange. It offers programs and academic initiatives to help researchers and experts collaborate, ensuring that Korean scientific achievements receive global recognition. K-BioX also provides mentorship, research support, and networking opportunities to enhance competitiveness in the global research landscape while nurturing the next generation of life science talent.

Experience a research environment without language barriers with EventCAT.

Need more information?

Feel free to reach out to us
and we'll get back to you within one business day.

Contact Us